Total Payments
$3,175
2024 Payments
$47.51
Companies
20
Transactions
101
Medicare Patients
4,461
Medicare Billing
$317,656
Payment Breakdown by Category
Travel$1,728 (54.4%)
Food & Beverage$1,313 (41.4%)
Other$105.63 (3.3%)
Education$27.75 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $1,728 | 1 | 54.4% |
| Food and Beverage | $1,313 | 88 | 41.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $105.63 | 1 | 3.3% |
| Education | $27.75 | 2 | 0.9% |
| Unspecified | $0 | 9 | 0.0% |
Payments by Type
General
$3,175
92 transactions
Ownership
$0
9 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UroGPO LLC | $1,790 | 7 | $0 (2020) |
| Janssen Biotech, Inc. | $804.51 | 61 | $0 (2020) |
| Amgen Inc. | $163.47 | 5 | $0 (2019) |
| PFIZER INC. | $61.71 | 5 | $0 (2019) |
| Boston Scientific Corporation | $60.60 | 1 | $0 (2023) |
| Astellas Pharma US Inc | $38.43 | 2 | $0 (2019) |
| Sumitomo Pharma America, Inc. | $28.53 | 1 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $26.67 | 1 | $0 (2017) |
| Endo Pharmaceuticals Inc. | $25.71 | 2 | $0 (2019) |
| Ferring Pharmaceuticals Inc. | $25.71 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $47.51 | 4 | Sumitomo Pharma America, Inc. ($28.53) |
| 2023 | $60.60 | 2 | Boston Scientific Corporation ($60.60) |
| 2022 | $21.56 | 2 | Merck Sharp & Dohme LLC ($21.56) |
| 2021 | $27.75 | 3 | Myovant Sciences Inc. ($23.93) |
| 2020 | $26.48 | 3 | Janssen Biotech, Inc. ($26.48) |
| 2019 | $451.48 | 27 | Janssen Biotech, Inc. ($267.22) |
| 2018 | $2,195 | 33 | UroGPO LLC ($1,790) |
| 2017 | $345.26 | 27 | Janssen Biotech, Inc. ($168.73) |
All Payment Transactions
101 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/06/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Oncology | ||||||
| 05/06/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $28.53 | General |
| Category: HORMONE THERAPY | ||||||
| 2024 | SN Holdings, LLC | — | — | — | $0.00 | Ownership |
| 2024 | SN Holdings, LLC | — | — | — | $0.00 | Ownership |
| 09/22/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $60.60 | General |
| Category: General - Kidney Stone Disease_URO | ||||||
| 2023 | SN Holdings, LLC | — | — | — | $0.00 | Ownership |
| 09/29/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: ONCOLOGY | ||||||
| 2022 | SN Holdings, LLC | — | — | — | $0.00 | Ownership |
| 04/14/2021 | Myovant Sciences Inc. | ORGOVYX (Drug) | Education | In-kind items and services | $23.93 | General |
| Category: HORMONE THERAPY | ||||||
| 04/06/2021 | Travere Therapeutics, Inc. | Thiola (Drug) | Education | In-kind items and services | $3.82 | General |
| Category: Kidney Stones | ||||||
| 2021 | SN Holdings, LLC | — | — | — | $0.00 | Ownership |
| 03/06/2020 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Oncology | ||||||
| 02/24/2020 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Oncology | ||||||
| 2020 | UroGPO LLC | — | — | — | $0.00 | Ownership |
| 12/13/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Oncology | ||||||
| 12/13/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $5.91 | General |
| Category: Oncology | ||||||
| 11/15/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Oncology | ||||||
| 11/15/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $7.22 | General |
| Category: Oncology | ||||||
| 11/06/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $6.30 | General |
| Category: Oncology | ||||||
| 10/10/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Oncology | ||||||
| 10/10/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $5.91 | General |
| Category: Oncology | ||||||
| 09/20/2019 | Amgen Inc. | XGEVA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $105.63 | General |
| Category: Oncology | ||||||
| 09/14/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Oncology | ||||||
| 09/14/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $5.91 | General |
| Category: Oncology | ||||||
| 08/15/2019 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,136 | 3,115 | $373,608 | $75,085 |
| 2022 | 15 | 953 | 2,501 | $307,425 | $58,043 |
| 2021 | 22 | 1,150 | 4,497 | $400,127 | $87,239 |
| 2020 | 21 | 1,222 | 3,378 | $428,346 | $97,289 |
Total Patients
4,461
Total Services
13,491
Medicare Billing
$317,656
Procedure Codes
83
All Medicare Procedures & Services
83 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 151 | 185 | $70,300 | $15,011 | 21.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 171 | 198 | $53,460 | $12,045 | 22.5% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 13 | 75 | $24,750 | $10,066 | 40.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 48 | 48 | $26,288 | $5,380 | 20.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 23 | 28 | $19,432 | $5,046 | 26.0% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 53 | 67 | $46,285 | $3,865 | 8.3% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 11 | 12 | $16,997 | $3,744 | 22.0% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 37 | 37 | $30,564 | $3,294 | 10.8% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 31 | 43 | $12,425 | $2,740 | 22.0% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 15 | 15 | $14,605 | $2,731 | 18.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 31 | 31 | $11,133 | $2,150 | 19.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 15 | $7,950 | $2,075 | 26.1% |
| 51705 | Simple change of bladder tube | Office | 2023 | 11 | 26 | $8,172 | $1,800 | 22.0% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 208 | 229 | $13,969 | $1,649 | 11.8% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 12 | 24 | $5,472 | $1,135 | 20.7% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2023 | 37 | 37 | $4,181 | $878.15 | 21.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 175 | 189 | $2,835 | $639.24 | 22.5% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 13 | 14 | $1,034 | $262.65 | 25.4% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 21 | 1,776 | $1,776 | $214.68 | 12.1% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 48 | 52 | $832.00 | $204.88 | 24.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 14 | $1,148 | $153.55 | 13.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 142 | 165 | $60,525 | $14,722 | 24.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 223 | 260 | $67,640 | $13,685 | 20.2% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 34 | 43 | $28,681 | $7,366 | 25.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 58 | 58 | $30,972 | $5,485 | 17.7% |
About Dr. Douglas Hoff, MD
Dr. Douglas Hoff, MD is a Urology healthcare provider based in Springfield, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801815519.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Douglas Hoff, MD has received a total of $3,175 in payments from pharmaceutical and medical device companies, with $47.51 received in 2024. These payments were reported across 101 transactions from 20 companies. The most common payment nature is "Travel and Lodging" ($1,728).
As a Medicare-enrolled provider, Hoff has provided services to 4,461 Medicare beneficiaries, totaling 13,491 services with total Medicare billing of $317,656. Data is available for 4 years (2020–2023), covering 83 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Springfield, OR
- Active Since 07/19/2006
- Last Updated 09/28/2022
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1801815519
Products in Payments
- Erleada (Drug) $579.97
- ZYTIGA (Drug) $198.06
- XGEVA (Biological) $105.63
- Prolia (Biological) $57.84
- ORGOVYX (Drug) $52.46
- SUTENT (Drug) $36.30
- PROVENGE (Drug) $26.67
- ERLEADA (Drug) $26.48
- XTANDI (Drug) $25.88
- FIRMAGON (Drug) $25.71
- XIAFLEX (Biological) $25.71
- KEYTRUDA (Biological) $21.56
- Xofigo (Drug) $21.56
- Myrbetriq (Drug) $20.24
- PLUVICTO (Drug) $18.98
- BOTOX THERAPEUTIC (Biological) $18.63
- MYRBETRIQ (Drug) $18.19
- Urolift - UL400 (Device) $16.49
- TOVIAZ (Drug) $12.24
- OFIRMEV (Drug) $11.72
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Springfield
Bryan Mehlhaff, Md, MD
Urology — Payments: $1.5M
Urology $1.5M
Kevin Mcvary, Md, MD
Urology — Payments: $405,504
Urology $405,504
Bradley Schwartz, M.d, M.D
Urology — Payments: $105,537
Urology $105,537
Robert Nadler, Md, MD
Urology — Payments: $93,691
Urology $93,691
Kevin Krughoff
Urology — Payments: $54,104
Urology $54,104
Dr. Eric Espinosa
Urology — Payments: $23,023
Urology $23,023